|
Originally published In Press as doi:10.1074/jbc.M102002200 on June 6, 2001
J. Biol. Chem., Vol. 276, Issue 34, 32122-32128, August 24, 2001
Sucrase-isomaltase Gene Transcription Requires the
Hepatocyte Nuclear Factor-1 (HNF-1) Regulatory Element and Is Regulated
by the Ratio of HNF-1 to HNF-1 *
François
Boudreau ,
Yi
Zhu, and
Peter G.
Traber§
From the Division of Gastroenterology, Department of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104
Received for publication, March 5, 2001, and in revised form, May 30, 2001
 |
ABSTRACT |
The mouse sucrase-isomaltase (SI) gene is
an enterocyte-specific gene expressed in a complex developmental
pattern. We previously reported that a short, evolutionarily conserved
gene promoter regulates developmental expression of SI in mouse small
intestine. Herein, we investigated the role of a hepatocyte nuclear
factor-1 (HNF-1) cis-acting element to regulate SI gene
expression in vivo. Transgenic SI gene constructs with a
mutated HNF-1 element (SIF3) revealed a strong reduction in promoter
activity in comparison with a wild-type construct in mice and during
Caco-2 cell differentiation. Nuclear proteins isolated from enterocytes
showed increased binding of the HNF-1 complex with a concomitant
decrease in the HNF-1 -containing complex to the SIF3 element both
during the suckling-weaning developmental transition and Caco-2 cell
differentiation. These changes coincided with a strong induction of SI
gene transcription. In transfection experiments, HNF-1 activated the
SI promoter via the SIF3 element, and co-expression of HNF-1
impaired this transcriptional activation. These findings demonstrate
the essential role of the HNF-1 regulatory element to support SI gene
transcription in vivo and suggest that the ratio of
HNF-1 to HNF-1 plays a role in the transcriptional activity of
this gene during intestinal development.
 |
INTRODUCTION |
Sucrase-isomaltase (SI)1
is an intestine-specific gene that is expressed in complex patterns in
epithelial cells during development along the cephalocaudal and the
crypt-villus axis of the intestine (1-3). In the mouse intestine, SI
is initially expressed at low levels late in fetal development when the
stratified endoderm cells transform into a columnar epithelium with
nascent villi (3). This low level of SI expression is maintained
through birth and the first two postnatal weeks of life (3). Between days 16 and 17, there is a dramatic induction in SI expression that
occurs in concert with other changes in gene expression that results in
the phenotype of the adult intestine (3). During this transition and
throughout adult life, there is a prominent induction of SI mRNA in
enterocytes located at the crypt-villus junction. SI mRNA is
abundant in enterocytes from the base of villi to the midvillus toward
the tip, resulting in low levels in villus tip cells (4, 5). This
pattern of expression mirrors critical developmental and
differentiation transitions in the intestine. Therefore, SI has served
as a useful model to investigate the molecular mechanisms that
orchestrate intestinal developmental transitions.
We have mapped regions of the SI gene that are important to
recapitulate its complex expression during mouse intestinal development using transgenic mice (1-3). This analysis shows that the crucial regulatory elements that direct patterns of enterocyte expression are
located between nucleotides 201 and +54 of the SI promoter. This
short, evolutionarily conserved mouse SI gene promoter directs transcription to enterocytes in developmental and
differentiation-dependent patterns (3). Since these
transgenic constructs are able to recapitulate the expression profile
of the endogenous gene during development, we conclude that increased
expression of the SI gene at the suckling-weaning transition is due
predominantly to induction of transcription. Moreover, the crucial
regulatory elements that direct patterns of enterocyte expression are
located between nucleotides 201 and +54 of the SI promoter.
Further studies of the human SI promoter in cell lines have identified
three major positive regulatory elements, sucrase-isomaltase footprint
1 (SIF1), SIF2, and SIF3 (6, 7). Caudal-related homeodomain proteins
(Cdx1 and Cdx2) interact with the SIF1 element and induce gene
transcription in vitro (8, 9). The SIF2 and SIF3 elements of
the human SI promoter interact with HNF-1 proteins to regulate
transcription (10). It is currently unclear whether these proteins
interact with the SI promoter in vivo to regulate gene
transcription during intestinal development.
In this study, we investigate the role of HNF-1 proteins in the
transcriptional regulation of the SI promoter during postnatal intestinal development. HNF-1 and HNF-1 are transcription factors distantly related to homeodomain proteins that bind to DNA as either
homodimers or heterodimers (11). They are expressed in a variety of
tissues including liver, kidney, intestine, stomach, and pancreas and
have been implicated in the regulation of multiple genes (12-17). In
this report, we demonstrate that mutagenesis of the SIF3 element
strongly impairs the activity of SI promoter in transgenic mice and
Caco-2 cells. Using intact nuclear proteins from neonatal mouse
intestinal epithelial cells and Caco-2 cells, we show that the pattern
of protein binding to the SIF3 element changes at a period when SI
expression is dramatically increased. We find that an increase in the
ratio of HNF-1 to HNF-1 reduces SI promoter activity. Taken
together, these data confirm an essential role for the HNF-1
element to regulate expression of the SI gene during intestinal
development and enterocyte differentiation.
 |
EXPERIMENTAL PROCEDURES |
Plasmid Construction and Mutagenesis--
The 201 to
+54 mSI-hGH construct has been described elsewhere (3). Point
mutagenesis of the 201 to +54 mSI-hGH plasmid was performed using the
Transformer site-directed mutagenesis kit
(CLONTECH). The following oligonucleotide was
designed to create point mutations (underlined) within the SIF3
element: SIF3m, 5'-GTAGAAATAACACAGGTATTAAGTAACTTGGCATGTC-3'.
Integrity of the mutant construct was confirmed by sequence analysis.
The 8.5 to +54 SIF3m mSI-hGH plasmid was constructed in two steps.
First, the 8.5 to +54 mSI-hGH construct (2) was digested with
XbaI and SphI to discard the 3424 to +54
mSI/hGH portion. The remaining sequence was used to subclone the
XbaI-SphI 201 to +54 SIF3m mSI/hGH insert
digested from the 201 to +54 SIF3m mSI-hGH vector to create the 8.5
to 3.4/ 201 to +54 SIF3m mSI-hGH vector. The 3424 to 201
XbaI fragment digested from the 8.5 to +54 mSI-hGH plasmid
was then inserted in the 8.5 to 3.4/ 201 to +54 SIF3m mSI-hGH
vector to create the 8.5 to +54 SIF3m mSI-hGH plasmid. Correct
orientation of the 3424 to 201 integrated fragment as well as the
presence of the SIF3 mutation in the 201 to +54 segment was confirmed
by sequence analysis. Portions of the human and mouse ribosomal protein
36B4 mRNA and the human HNF-1 mRNA were amplified by reverse
transcriptase-PCR. Reverse transcription reactions were performed as
described previously (3) with the use of either RNA extracted from
Caco-2 cells or mouse small intestine. For PCR, the following paired
primers were used for amplification: for h36B4, h36B4up
(5'-ATGTGAAGTCACTGTGCCAG-3') and h36B4down (5'-CTCAGGATTTCAATGGTGCC-3'); for m36B4, m36B4up
(5'-ATGTGAGGTCACTGTGCCAG-3') and m36B4down
(5'-AGGTGTACTCAGTCTCCACA-3'); and for hHNF-1 , HNF1 up (5'-GGAAATGCCTGTGTGAGTAG-3') and HNF1 down
(5'-GAAGGCCAGGTTCTCAGCAG-3'). PCR amplification was carried out for 35 cycles with denaturation at 95 °C, annealing of the primers at
55 °C, and reaction extension at 72 °C, each for 1 min. A
113-base pair fragment extending from positions 431 to 544 of h36B4, a
420-base pair fragment from positions 428 to 848 of m36B4, and a
643-base pair fragment from position 2465 to 3108 of hHNF-1 cDNA
were subcloned into the pGEM-T easy vector (Promega, Madison, WI)
according to the manufacturer's recommendations. The integrity of
subcloned PCR products was confirmed by sequence analysis. The 132-bp
EcoRI-SmaI m36B4 fragment was further subcloned
in Bluescript KS vector (Stratagene, La Jolla, CA) to create the
KS-m36B4 plasmid.
Transgenic Mice--
The promoter/reporter 8.5 to +54 SIF3m
mSI-hGH construct was released by digestion with SalI and
SphI and purified. Transgenic mice were produced by the
Transgenic Core Facility at the University of Pennsylvania. The DNA
construct was injected into the male pronucleus of fertilized eggs and
implanted into pseudopregnant females using standard methodology. DNA
from tail biopsies of resulting mice was extracted using the QIAamp
Tissue kit (Qiagen Inc., Valencia, CA). The presence of the transgene
in mouse genomic DNA was determined by PCR and Southern analysis as
described previously (2, 3). Transgene founders of the BGSJL/F1 strain
(Jackson Laboratory, Bar Harbor, ME) were bred with normal CD1 mice
(Charles River), and offspring were analyzed for the transgene by
PCR.
Cell Culture--
A Caco-2 cell line was obtained from the
American Tissue Culture Collection (Manassas, VA). The Caco-2-15 cell
line was kindly provided by Dr. J.-F. Beaulieu (Université de
Sherbrooke, Québec). Cells were maintained in Dulbecco's
modified Eagle's medium supplemented with 4.5 g/liter
D-glucose, 25 mM HEPES, 10% fetal bovine
serum, 50 units/ml penicillin, and 50 µg/ml of streptomycin in 5%
CO2.
Isolation of Nuclear Proteins from Intestinal
Epithelium--
Nuclear protein was isolated from neonatal mice by a
modification of a method previously used by our laboratory for adult mouse intestine (6). Briefly, mice were anesthetized with sodium pentobarbital (0.15 ml for adult, 0.05 ml for neonatal mice), and the
intestine was exposed through a midline incision. The distal small
intestine was rinsed with 10 ml of 1× calcium/magnesium-free Hanks'
balanced salts (CMF). The thoracic cavity was opened, and the left
ventricle was perfused through a needle with 1× CMF for 3 min with a
hydrostatic head of 5 feet. Perfusion fluid was allowed to exit through
an incision in the right atrium. Adequacy of the perfusion was
determined by homogenous blanching of the intestine and liver. The
section of bowel that was initially rinsed was washed with 10 ml of 1×
CMF buffer containing 2 µg/ml leupeptin, 2 µg/ml aprotinin, 2 µg/ml bestatin, 2 µg/ml pepstatin A, and 0.2 mM
phenylmethylsulfonyl fluoride to collect epithelial cells. The cells
were washed twice with 1× CMF containing proteinase inhibitors.
Nuclear proteins were then isolated from the epithelial cell suspension
using the same method as previously described for cells in culture
(6).
Following each intestinal perfusion, the isolated epithelium was
stained with trypan blue to examine cell integrity. Cell isolates with
greater than 5% trypan blue-positive cells, indicating disrupted
membranes, were discarded.
Protein Analysis--
Nuclear proteins were isolated from Caco-2
cells or intestinal epithelial cells (see above), and EMSA was
performed exactly as described previously (8). HNF-1
affinity-purified goat polyclonal antibody raised against a peptide
mapping to the carboxyl terminus of human HNF-1 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) and HNF-1 affinity-purified
rabbit polyclonal antibody raised against a peptide mapping to the N
terminus of human HNF-1 2
were used for supershift experiments. For Western blot analysis, 20 µg of total protein extract was analyzed by a 4-12% Bis-Tris NuPAGE
(Invitrogen, Carlsbad, CA) electrophoresis and transferred to an
Immobilon-P membrane. The membrane was blocked with 10% nonfat dry
milk in phosphate-buffered saline and 0.1% Tween for overnight. The
membrane was then incubated for 3 h with the primary antibody. The
following antibodies were used: HNF-1 affinity-purified rabbit
polyclonal antibody raised against a peptide mapping to amino acids
80-284 of human HNF-1 that reacts with HNF-1 and HNF-1
proteins (H-205, Santa Cruz Biotechnology) and Cdx2 affinity-purified rabbit polyclonal antibody raised against a peptide mapping to the N
terminus of murine Cdx2.3 The
membrane was washed two times in phosphate-buffered saline with 0.1%
Tween and incubated with the secondary antibody anti-rabbit/horseradish peroxidase (Amersham Pharmacia Biotech) for 45 min at room temperature. The membrane was then washed three times and developed with the ECL-Plus Western blotting kit (Amersham Pharmacia Biotech).
For immunohistochemistry, tissues were fixed in 10% buffered formalin
phosphate (Fisher) and embedded in paraffin in Swiss roll orientation
such that the entire length of the intestinal tract could be identified
on a single section. Tissue sections were stained for hGH protein and
counterstained with eosin as described previously (1-3).
RNA Analysis--
RNA was extracted from multiple tissues using
a CsCl gradient method as previously described (2) or from cultured
cells using TRIzol (Life Technologies, Inc.). Ribonuclease (RNase)
protection assays were performed using the RPA II kit (Ambion, Austin,
TX) according to the manufacturer's recommendations. Riboprobes for the detection of human SI and hGH mRNA were prepared as previously described (1). The riboprobe for the detection of hHNF-1 was prepared by digesting pGEM-hHNF-1 with XhoI, and
transcripts were synthesized using SP6 RNA polymerase to yield a probe
that protects a 326-bp region located in the 3'-noncoding region of the
hHNF-1 cDNA. As a control for total RNA integrity, human and
mouse riboprobes for the detection of the ribosomal protein 36B4
mRNA (18) were synthesized. h36B4 riboprobe was prepared by
digesting pGEM-h36B4 with SacII and with SP6 RNA polymerase to yield a probe that protected 113 nt. m36B4 riboprobe was prepared by
digesting KS-m36B4 with HindIII and transcribed with T7 RNA polymerase to yield a probe that protected 132 nt. Northern blot was
performed as described elsewhere (19). NotI-XhoI
mouse HNF-1 cDNA fragment digested from pBJ5-HNF-1 plasmid
(16) was used to detect the human HNF-1 mRNA, since comparison
of cDNA nucleotide sequences showed more than 91% homology. h36B4
was used as a control for RNA integrity.
Transient Transfections--
Transfections were performed using
LipofectAMINE (Life Technologies) according to the manufacturer's
recommendations. Cells at 50-60% confluence were incubated with 1.5 µg of total DNA and 2.5 µl of LipofectAMINE/ml of OPTI-MEM for
5 h. The medium was then changed to Dulbecco's modified Eagle's
medium complete medium containing 10% fetal bovine serum. For
transient transfections, luciferase activity was determined 48 h
after the transfection using the luciferase assay kit (Promega Biotech,
Madison, WI). Each experiment was repeated three times in triplicate.
pCMV- -galactosidase expression vector was co-transfected in each
experiment as a measure of transfection efficiency, and the results
were reported as light units per unit of -galactosidase. For stable
transfections, Caco-2/15 cells were trypsinized 48 h following
transfection and maintained in selection medium containing 1 mg/ml G418.
 |
RESULTS |
Mutagenesis of the SIF3 Element Impairs SI Promoter Activity in
Transgenic Mice--
To evaluate the functional role of the SIF3
element in the regulation of the SI gene in the intact mouse intestinal
epithelium, we designed transgenic constructs harboring point mutations
within this element that linked nucleotides 8.5 to +54 of the mSI
gene to the hGH reporter gene (Fig.
1A). The wild-type construct
supports hGH expression in enterocytes of transgenic mice and has been shown to direct copy number-dependent and insertion
site-independent transgene expression in multiple trangenic lines (2).
The SIF3m mutation has been previously shown to abolish in
vitro interaction with HNF-1 proteins (10).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 1.
RNase protection analysis of transgene
expression. A, diagram of SI reporter constructs used
to generate transgenic mice. B, total RNA (10 µg) isolated
from intestinal tissues of a female F1 mouse from
founder 17 with the genomic integrated 8.5 to +54 mSI-hGH
construct were used as a reference control in an RNase protection assay
for the simultaneous detection of hGH and 36B4 mRNA. C,
total RNA was isolated from intestinal tissues of four different adult
founder lines obtained with the 8.5 to +54 SIF3m mSI-hGH construct
and was analyzed as described for A. D,
expression level of hGH mRNA was quantitated using a PhosphorImager
(Molecular Dynamics, Inc., Sunnyvale, CA) and reported to m36B4
mRNA levels. Du, duodenum; PJ, proximal
jejunum; DJ, distal jejunum; IL, ileum;
Ce, cecum; PC, proximal colon; DC,
distal colon; WT, wild type.
|
|
Four founders (numbers 17, 28, 29, and 41) derived from the
construct 8.5 to +54 SIF3m mSI-hGH were found to have 1, 31, 7, and
10 copies of the transgene integrated into their genome, respectively
(data not shown). The effect of the SIF3 mutation on hGH expression in
these transgenic lines was compared with the previously characterized
F0(17)F1(32) transgenic line that contained five copies of the wild-type 8.5 to +54 mSI-hGH transgene construct (2). Total RNA isolated from different portions of the
intestine was analyzed by a RNase protection assay. Each RNA sample was
incubated with probes for hGH and an internal control (36B4) in the
same hybridization solution in order to correlate hGH mRNA levels
among these different lines. The wild-type
F0(17)F1(32) transgene line showed high level
expression of hGH in the small intestine (Fig. 1B), as
previously reported (2). In contrast, the expression of hGH mRNA in
the transgenic lines carrying the mutant construct was reduced by more
than 95% in the duodenum and proximal and distal jejunum of
founders 17, 29, and 41 and by 85% in founder 28 as compared with the expression found in the wild-type transgene line
(Fig. 1, B-D). Expression levels were similarly decreased
in the ileum, although the pattern was somewhat more variable (Fig.
1D). No hGH expression was detected in transgenic lines
harboring the same SIF3 mutation within a shorter 201 to +54 mSI/hGH
transgene as compared with the wild type short transgene (data not shown).
To verify the cellular distribution of hGH expression in the 8.5 to
+54 SIF3m mSI-hGH transgenic lines, immunodetection was performed.
Intestinal sections obtained from offspring of transgenic mice
containing the wild-type transgene construct showed high level
expression of hGH in differentiated enterocytes of the small intestine
(Fig. 2A). In contrast, weak
expression was detected in enterocytes randomly distributed along the
proximal jejunum villi from offspring of founders 28 and 41, as illustrated in Fig. 2, B and C. Expression was
restricted to the proximal jejunum with no detectable hGH protein
throughout the entire small bowel as opposed to the wild-type
transgenic control (data not shown) (2). In summary, the data obtained
from these transgenic constructs demonstrate a crucial role for the
SIF3 element to regulate SI promoter activity in the small intestinal
epithelium.

View larger version (128K):
[in this window]
[in a new window]
|
Fig. 2.
Immunohistochemical detection of hGH protein
in proximal jejunum from adult transgenic mouse. Tissue sections
from each transgenic line were stained for detection of hGH protein and
counterstained with eosin. Sections from offspring of
founder 17 that contains the wild-type transgene construct
showed strong pattern of hGH detection in enterocytes (A).
Sections from offspring of founder 28 (B) and
founder 41 (C) with the mutant SIF3 transgene
showed low levels of hGH protein in randomly distributed enterocytes
(arrows).
|
|
The SIF3 Element Is Important in the Regulation of SI
Promoter Activity in Caco-2 Cells--
The molecular mechanisms
involved in the SIF3-dependent regulation of SI gene
expression was further examined in the Caco-2 cell line, which has been
extensively used as a model of enterocytic differentiation (20-22). We
used the Caco-2/15 clone derived from the parent Caco-2 cell line that
spontaneously differentiates in postconfluence with concomitant high
induction of SI expression (23). We investigated the role of the
SIF3 element to regulate SI promoter activity during Caco-2 cell
differentiation. The constructs 8.5 to +54 mSI-hGH and 8.5 to +54
SIF3m mSI-hGH were co-transfected with a neomycin resistance expression
vector (pRC/CMV) to stably transfect Caco-2/15 cells. As a control,
Caco-2/15 cells were co-transfected with the empty hGH reporter and
pRC/CMV. Because of the heterogeneous properties of Caco-2 cell lines
with regards to SI expression (24), the entire neomycin-resistant
population was used for further analysis. Expression of human SI, hGH,
and h36B4 was determined in RNA samples isolated at different times of
cell confluence. Expression of the 8.5 to +54 mSI-hGH
construct increased in a similar manner to endogenous human SI mRNA
during cellular differentiation (Fig.
3A). In contrast to the
wild-type construct, the SIF3 mutant construct showed stable levels of
hGH expression at postconfluent stages as demonstrated in day 7 and 14 samples (Fig. 3A). The level of hGH expression in the
preconfluent state was comparable with the level detected in Caco-2/15
co-transfected with the empty vector, suggesting that the SI promoter
is transcriptionally inactive in preconfluent cells (Fig. 3).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of SIF3 mutagenesis on SI promoter
activity during Caco-2 cell differentiation. A,
Caco2-15 cells were stably transfected with the neomycin resistance
pRc/CMV vector in combination with either the empty hGH reporter vector
(pøhGH), the mSIwt promoter/hGH reporter vector, or the SIF3 mutated
mSI promoter/hGH reporter vector. Total RNA was extracted from
G418-resistant cell populations at different days of Caco2 cell
confluence (PC, preconfluent; C, confluent;
+7, 7 days after confluence; +14, 14 days after
confluence). An RNase protection assay was performed using human SI,
hGH, and h36B4 riboprobes. B, intensity of the signals was
measured from three or four independent experiments by densitometric
analysis using a PhosphorImager. The expression level of hGH mRNA
was reported to h36B4 signal and represented graphically (mean ± S.D.).
|
|
The DNA-binding Pattern of HNF-1 Proteins to the SIF3 Element Is
Modified during Mouse Intestinal Development and Caco-2 Cell
Differentiation--
We next examined the pattern of nuclear protein
interaction with the SIF3 element during mouse intestinal development.
To obtain high quality nondegraded protein, we performed a whole-body perfusion to isolate enterocytes and extract nuclear proteins from
mouse intestines at different time points throughout the suckling-weaning transition. To ensure that our method isolated both
crypt- and villus-associated cells, we isolated mRNA from the
epithelial cells, and the expression of specific intestinal epithelial
genes was examined by Northern analysis. We found that both SI (villus
marker) and cryptdin (crypt marker) mRNAs were found in cell
extracts (data not shown). Therefore, both crypt and villus cells were
represented in the epithelial cell preparations. EMSA was then
performed using a labeled SIF3 DNA probe, and equal amounts of nuclear
extracts from intestinal epithelial cell pools were collected at
different time before and after weaning.
The SIF3 element produced two specific complexes that were competed by
the addition of a 100-fold excess of unlabeled SIF3 oligonucleotides
(Fig. 4A). Although both
complexes were detected at each time points during intestinal
development, the relative intensity of the two complexes varied. The
lower complex (labeled B in Fig. 4A) was more
abundant than the upper complex (A) at postnatal day 13, a
time at which SI mRNA is just detectable (3). By postnatal day 19, the ratio of A to B complexes shifted, resulting in more abundant
complex A relative to B. Importantly, this period of time coincides
with dramatic induction of SI mRNA levels in the small bowel (3).
The change in ratio of these complexes was further amplified in adult
mice (Fig. 4A). Analysis of nuclear extracts binding to the
mouse SIF2 element showed no specific DNA-protein interaction during
mouse intestinal development. A similar analysis was then performed
using the labeled SIF3 DNA probe and an equal amount of nuclear
extracts prepared from preconfluent and postconfluent Caco-2 cells. The
SIF3 element produced two protein-DNA complexes (A and
B in Fig. 4B), both of which were eliminated by
competition with a 10-fold excess of unlabeled SIF3 oligonucleotides.
The intensity of complex A increased at postconfluent day 7 with a
simultaneous decrease in intensity of complex B, a pattern that was
maintained at postconfluent day 14 (Fig. 4B). The addition
of affinity-purified polyclonal HNF-1 antibodies to the binding
reaction supershifted both complex A and complex B, while HNF-1
antibodies supershifted only complex B, confirming that complex A is
composed of HNF-1 homodimers and complex B is composed of
HNF-1 /HNF-1 heterodimers (Fig. 4C). These observations suggested that HNF-1 isoforms are differentially regulated during the
suckling-weaning transition and Caco-2 cell differentiation. Therefore,
we examined the expression of HNF-1 and HNF-1 mRNA at
different times during Caco-2 cell growth and differentiation. RNase
protection assay performed with specific hHNF-1 and h36B4 probes
showed no significant change in HNF-1 mRNA levels in comparison with 36B4 mRNA levels before or after Caco-2 cell confluence (Fig. 5A). However, HNF-1
mRNA levels were reduced more than 3-fold at postconfluence as
determined by Northern analysis (Fig. 5B). Immunoblots were
performed to test whether changes in protein expression correlated with
RNA expression of these isoforms during Caco-2 cell differentiation. No
major change in HNF-1 protein level was observed before or after
Caco-2 cell differentiation (Fig. 5C). However, HNF-1
protein level was decreased more than 2.5-fold at postconfluence (Fig.
5C). Interestingly, CDX2 protein content was not
significantly modified during Caco-2 cell differentiation (Fig.
5C).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 4.
EMSA of the SIF3 element during intestinal
development and Caco-2 differentiation. A, a labeled
SIF3 oligonucleotide was used for EMSA as previously described (6). 10 µg of nuclear extracts of intestinal epithelial cells isolated from
postnatal day 13 (P13) to postnatal day 30 (P30)
were used for each binding reaction. Specific complexes are marked
A and B. Competitions were performed with
100-fold molar excess of the SIF3 unlabeled oligos. B,
nuclear extracts were prepared from preconfluent (PC),
confluent (C), and postconfluent (+7,
+14) Caco2 or Caco2-15 cells and incubated with
32P-labeled SIF3 probe. Specific complexes are marked
A and B. Specificity of the complexes was
verified by competition with a 10-fold excess of double-stranded
oligonucleotides. C, HNF1 and HNF-1 polyclonal
antibodies were added to the binding reaction for supershift
analysis.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
Expression of HNF-1
and HNF-1 during Caco-2 cell
differentiation. A, total RNA was extracted at
different days of Caco2 cell confluence (PC, preconfluent;
C, confluent; +7, 7 days after confluence;
+14, 14 days after confluence). RPA was performed using
hHNF1 and h36B4 riboprobes. B, Northern analysis was
performed using sequentially a mouse HNF1 32P-labeled
cDNA probe and a h36B4 32P-labeled cDNA probe as a
control for total RNA loading. C, Western blot analysis was
performed using HNF-1 and Cdx2 polyclonal antibodies on similar amounts
of total protein extracted at different days of Caco2 cell
confluence.
|
|
The Ratio of HNF-1 to HNF-1 Regulates SI Promoter Activity in
Caco-2 Cells --
We then evaluated whether changes in the relative
levels of HNF-1 isoforms have a functional effect on the regulation of
SI gene transcription. Co-transfection of an HNF-1 expression vector with the 201 to +54 SI promoter construct produced an increase in
transcriptional activity of the SI promoter construct in Caco-2 cells
(Fig. 6A). In contrast,
expression of HNF-1 led to minimal activation of the construct (Fig.
6A). A point mutation in the SIF3 element that abolishes
binding of HNF-1 proteins to the site (10) eliminated the positive
effect of HNF-1 on the SI promoter (Fig. 6A). We then
tested whether HNF-1 could counter the positive effect of HNF-1 .
High amounts of HNF-1 expression vector resulted in decreased
activation of the SI promoter construct when a constant amount of
HNF-1 was maintained (Fig. 6B). Nuclear complexes binding to the SIF3 element reflected the increased ratio of HNF-1 to HNF-1 in these co-transfection experiments where the HNF-1
homodimer complex decreased with associated augmentation in both
HNF-1 /HNF-1 heterodimer and HNF-1 homodimer complexes (Fig.
6C). Both HNF-1 homodimer and heterodimer complexes were
detected in the condition where HNF-1 was co-transfected alone (Fig.
6C, third lane), since Caco2 cells
express both endogenous HNF-1 and HNF-1 proteins (Fig.
5C). These results confirm that the ratio of HNF-1 proteins binding to the SIF3 element is critical in the regulation of the SI
promoter in intestinal epithelial cells.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of HNF1 and
HNF1 on SI transcriptional activity in Caco-2
cells. A and B, Caco-2/15 cells were transfected using
LipofectAMINE (Life Technologies) with 300 ng of either 201 to +54
mSI-pGL2basic (WT) or 201 to +54 SIF3m mSI-pGL2basic
(SIF3m) reporter vectors, 100 ng of
pCMV- -galactactosidase, and various amounts of HNF-1 or HNF-1
expression vectors or both, as indicated. The pRC/CMV plasmid was used
as an empty control vector to calibrate the various amounts of
expression vectors used in each condition. Results obtained in
triplicate were reported as -fold difference (mean ± S.D.) from
transfection with the reporter construct alone and are representative
of three independent experiments. C, EMSA of the SIF3
element was performed with nuclear extracts from Caco-2/15 cells
co-transfected as described for A and B.
|
|
 |
DISCUSSION |
The epithelium lining the intestine undergoes a complex series of
developmental transitions that result in the functional adult
intestinal mucosa. Examination of the mechanisms that direct expression
of developmentally regulated genes provides a better understanding of
these developmental processes. In postnatal development, the
suckling-weaning transition is marked by profound changes in intestinal
gene expression and epithelial cell function. During this time, there
is a marked induction of SI expression, which parallels other important
developmental transitions in the intestine and therefore has served as
a model for elucidating molecular regulation of developmental events
(25). Our results show that one cis-acting DNA regulatory element is
critically important to support SI gene transcription during postnatal
development and intestinal epithelial cell differentiation. Moreover,
the activity of this regulatory site is dependent on the relative amounts of two related transcription factors, HNF-1 and
HNF-1 .
Previous work from our laboratory has suggested a role for HNF-1
transcription factors to regulate human SI promoter activity (10). The
use of human nuclear extracts isolated from intestinal cell lines has
led to the identification of two different elements, SIF2 and SIF3,
both interacting with HNF-1 proteins (6, 10). Mutation of the SIF3
element strongly reduced mouse SI promoter activity in transgenic mice
and Caco-2 cells. HNF-1 -dependent induction of SI
promoter activity was strongly reduced when the SIF3 element was
disrupted in co-transfection experiments. The current studies show that
the SIF2 element is not functionally important for the mouse SI
promoter. No specific interaction was found with mouse intestinal
nuclear extracts and the mouse SIF2 element, most likely because the
second half of the mouse SIF2 element (AACATT) differs from the HNF-1
consensus site (ATTAAC). Moreover, there is one nucleotide difference
between the human and mouse genes in the first half-region of the
element. Therefore, we conclude that the SIF3 regulatory region solely
interacts with HNF1 proteins to regulate mouse SI gene expression at
the suckling-weaning transition.
The increase of the HNF-1 homodimer complex that binds to the SIF3
regulatory element correlates very well with the induction of SI gene
expression both at the suckling-weaning transition (3) and during
Caco-2 cell differentiation. Changes in the binding activity of
HNF-1 during Caco-2 cell differentiation have also been observed for
specific elements found in the human 1-antitrypsin
promoter (26). In this study, Northern analysis showed an increase in
the HNF-1 mRNA level during Caco-2 cell differentiation (26). We
were unable to detect significant change in HNF-1 mRNA and
protein levels with the use of two different Caco-2 cell lines.
Differences in the nature of the probe and methods used to detect the
messenger RNA may explain this discrepancy. The mechanisms involved in
the regulation of HNF-1 dimerization and interaction with the chromatin
in intestinal epithelial cells must be complex and will require
additional studies. One explanation for the increase in HNF-1
homodimers without any important change in HNF-1 protein content is
that the decrease in the ratio of HNF-1 to HNF-1 proteins would
lead to a redistribution in the composition of HNF1 complexes that
interact with the SIF3 element of the SI promoter.
There are major differences in the transactivation domains of HNF-1
proteins (16). HNF-1 has a positive transcriptional effect on some
binding sites such as those in albumin and -fetoprotein (27) or more
commonly no functional effect at all, such as in the -fibrinogen
promoter (16) and the CYP2E1 promoter (28). It has been demonstrated
that the relative abundance of both HNF-1 proteins can affect
vitamin-D-binding protein gene transcription (29). The inhibitory
effect of HNF-1 on HNF-1 has been suggested to be dependent on
several DNA binding sites where HNF-1 acts as a trans-dominant
inhibitor of HNF1-mediated enhancer activity (29). The mechanism by
which HNF-1 reduces HNF-1 transactivation of the mouse SI
promoter may be more complex, since a single DNA interacting site is
involved. The transactivation properties of HNF-1 have been shown to
rely on physical interactions with multiple coactivator proteins such
as CREB-binding protein and CBP-associated factor (30).
Interestingly, the region of HNF-1 necessary to interact with the
CBP-associated factor protein is absent in the HNF-1 protein
(30).
Changes in the binding of HNF-1 complexes cannot fully explain the
specificity of SI expression in the mature enterocyte, since HNF-1
is more abundant than HNF-1 in tissues where the SI gene is not
expressed (16). Furthermore, SI promoter activity is equally detected
in the mutant SIF3 and the wild-type mSI reporter constructs at the
onset of Caco-2 cell differentiation when SI mRNA expression
becomes detectable (Fig. 6). The SIF1 DNA regulatory element is crucial
for regulation of the SI promoter in cell lines (6, 7). The element
contains two binding sites for Cdx proteins, which are able to activate
SI promoter transcription via binding to this site. The Cdx regulatory
element is likely to be involved in the specificity of SI gene
expression in intestinal epithelial cells, because Cdx2 homeodomain
protein regulates both proliferation and differentiation of intestinal
epithelial cells (31) and is restricted to the intestinal epithelium
during mouse postnatal development (32). A close interaction between
Cdx2 and HNF-1 proteins represents an interesting hypothesis for the
spatial and time-dependent regulation of SI gene expression
during postnatal development. Such an interaction has been suggested to
promote lactase transcriptional activity as demonstrated by in
vitro studies (33).
In summary, we have showed that the SIF3 cis-acting element
is crucial to positively regulate an intestinal specific gene promoter
in vivo. We propose that the SIF3 element maintains a pivotal role in the control of SI promoter activity where binding of a
predominant HNF-1 homodimer complex promotes the interaction of
intestine-specific transcription factors and co-factors with the
promoter. Future studies on the in vivo interaction of
HNF-1, Cdx2, and co-factors during postnatal development will provide insights to elucidate the molecular mechanisms involved in the regulation of intestine-specific gene expression.
Acknowledgments--
We thank Drs. Debra G. Silberg and Eun Ran
Suh for critical review of the manuscript.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.This
work was supported by RO1-DK46704 (to P.G.T.) and
the Molecular Biology Core of the Center for Molecular Studies in
Digestive Diseases at the University of Pennsylvania (P30-DK50306).
Supported by a postdoctoral fellowship from the "Fonds de la
Recherche en Santé du Québec."
§
To whom correspondence should be addressed: 709 Swedeland Rd., P.O.
Box 1539, King of Prussia, PA 19406-0939. Tel.: 610-270-6016; Fax:
610-270-6116; E-mail: Peter_G_Traber@sbphrd.com.
Published, JBC Papers in Press, June 6, 2001, DOI 10.1074/jbc.M102002200
2
F. Boudreau and P. G. Traber, unpublished results.
3
E. H. H. M. Rings and P. G. Traber, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
SI, sucrase-isomaltase;
mSI, mouse SI;
SIF, sucrase-isomaltase footprint;
HNF-1, hepatocyte nuclear factor-1;
hHNF-1, human HNF-1;
hGH, human
growth hormone;
PCR, polymerase chain reaction;
bp, base pairs;
CMF, calcium/magnesium-free Hanks' balanced salts;
EMSA, electrophoretic
mobility shift assay.
 |
REFERENCES |
| 1.
|
Markowitz, A. J.,
Wu, G. D.,
Birkenmeier, E. H.,
and Traber, P. G.
(1993)
Am. J. Physiol.
265,
G526-G539
|
| 2.
|
Markowitz, A. J.,
Wu, G. D.,
Bader, A.,
Cui, Z.,
Chen, L.,
and Traber, P. G.
(1995)
Am. J. Physiol.
269,
G925-G939
|
| 3.
|
Tung, J.,
Markowitz, A. J.,
Silberg, D. G.,
and Traber, P. G.
(1997)
Am. J. Physiol.
273,
G83-G92
|
| 4.
|
Traber, P. G.
(1990)
Biochem. Biophys. Res. Commun.
173,
765-773
|
| 5.
|
Traber, P. G., Yu, L.,
Wu, G. D.,
and Judge, T. A.
(1992)
Am. J. Physiol.
262,
G123-G130
|
| 6.
|
Traber, P. G.,
Wu, G. D.,
and Wang, W.
(1992)
Mol. Cell. Biol.
12,
3614-3627
|
| 7.
|
Wu, G. D.,
Wang, W.,
and Traber, P. G.
(1992)
J. Biol. Chem.
267,
7863-7870
|
| 8.
|
Suh, E.,
Chen, L.,
Taylor, J.,
and Traber, P. G.
(1994)
Mol. Cell. Biol.
14,
7340-7351
|
| 9.
|
Taylor, J. K.,
Levy, T.,
Suh, E. R.,
and Traber, P. G.
(1997)
Nucleic Acids Res.
25,
2293-2300
|
| 10.
|
Wu, G. D.,
Chen, L.,
Forslund, K.,
and Traber, P. G.
(1994)
J. Biol. Chem.
269,
17080-17085
|
| 11.
|
Mendel, D. B.,
and Crabtree, G. R.
(1991)
J. Biol. Chem.
266,
677-680
|
| 12.
|
Baumhueter, S.,
Mendel, D. B.,
Conley, P. B.,
Kuo, C. J.,
Turk, C.,
Graves, M. K.,
Edwards, C. A.,
Courtois, G.,
and Crabtree, G. R.
(1990)
Genes Dev.
4,
372-379
|
| 13.
|
Emens, L. A.,
Landers, D. W.,
and Moss, L. G.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7300-7304
|
| 14.
|
Lee, Y. H.,
Sauer, B.,
and Gonzalez, F. J.
(1998)
Mol. Cell. Biol.
18,
3059-3068
|
| 15.
|
Lipson, K. E.,
and Baserga, R.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
9774-9777
|
| 16.
|
Mendel, D. B.,
Hansen, L. P.,
Graves, M. K.,
Conley, P. B.,
and Crabtree, G. R.
(1991)
Genes Dev.
5,
1042-1056
|
| 17.
|
Pontoglio, M.,
Barra, J.,
Hadchouel, M.,
Doyen, A.,
Kress, C.,
Bach, J. P.,
Babinet, C.,
and Yaniv, M.
(1996)
Cell
84,
575-585
|
| 18.
|
Clifford, J.,
Chiba, H.,
Sobieszczuk, D.,
Metzger, D.,
and Chambon, P.
(1996)
EMBO J.
15,
4142-4155
|
| 19.
|
Boudreau, F., Yu, S. J.,
and Asselin, C.
(1998)
DNA Cell Biol
17,
669-677
|
| 20.
|
Menard, D.,
and Beaulieu, J.-F.
(1994)
in
Membranes Physiopathology
(Bkaily, G., ed)
, pp. 319-341, Kluwer Academic Press, Norwell, MA
|
| 21.
|
Pinto, M.,
Robine-Leon, S.,
Appay, M.-D.,
Kedinger, M.,
Triadou, N.,
Dussaulx, E.,
Lacroix, B.,
Simon-Assmann, P.,
Haffen, K.,
Fogh, J.,
and Zweibaum, A.
(1983)
Biol. Cell
47,
323-330
|
| 22.
|
Zweibaum, A.,
and Chantret, I.
(1989)
in
Adaptation and Development of Gastrointestinal Function
(Smith, M. W.
, and Sepulveda, F. V., eds)
, p. 103, Manchester University Press, Manchester, United Kingdom
|
| 23.
|
Beaulieu, J. F.,
and Quaroni, A.
(1991)
Biochem. J.
280,
599-608
|
| 24.
|
Vachon, P. H.,
and Beaulieu, J. F.
(1992)
Gastroenterology
103,
414-23
|
| 25.
|
Traber, P. G.
(1998)
Phil. Trans. R. Soc. Lond. B Biol. Sci.
353,
911-914
|
| 26.
|
Hu, C.,
and Perlmutter, D. H.
(1999)
Am. J. Physiol.
276,
G1181-G1194
|
| 27.
|
Rey-Campos, J.,
Chouard, T.,
Yaniv, M.,
and Cereghini, S.
(1991)
EMBO J.
10,
1445-1457
|
| 28.
|
Liu, S. Y.,
and Gonzalez, F. J.
(1995)
DNA Cell Biol.
14,
285-293
|
| 29.
|
Song, Y. H.,
Ray, K.,
Liebhaber, S. A.,
and Cooke, N. E.
(1998)
J. Biol. Chem.
273,
28408-28418
|
| 30.
|
Soutoglou, E.,
Papafotiou, G.,
Katrakili, N.,
and Talianidis, I.
(2000)
J. Biol. Chem.
275,
12515-12520
|
| 31.
|
Suh, E.,
and Traber, P. G.
(1996)
Mol. Cell. Biol.
16,
619-625
|
| 32.
|
Silberg, D. G.,
Swain, G. P.,
Suh, E. R.,
and Traber, P. G.
(2000)
Gastroenterology
119,
961-971
|
| 33.
|
Mitchelmore, C.,
Troelsen, J. T.,
Spodsberg, N.,
Sjostrom, H.,
and Noren, O.
(2000)
Biochem. J.
346,
529-535
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Hino, K. Tsuchiya, T. Fukao, K. Kiga, R. Okamoto, T. Kanai, and M. Watanabe
Inducible expression of microRNA-194 is regulated by HNF-1{alpha} during intestinal epithelial cell differentiation
RNA,
July 1, 2008;
14(7):
1433 - 1442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Lussier, J.-P. Babeu, B. A. Auclair, N. Perreault, and F. Boudreau
Hepatocyte nuclear factor-4{alpha} promotes differentiation of intestinal epithelial cells in a coculture system
Am J Physiol Gastrointest Liver Physiol,
February 1, 2008;
294(2):
G418 - G428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ezaki, R.-J. Guo, H. Li, A. B. Reynolds, and J. P. Lynch
The homeodomain transcription factors Cdx1 and Cdx2 induce E-cadherin adhesion activity by reducing beta- and p120-catenin tyrosine phosphorylation
Am J Physiol Gastrointest Liver Physiol,
July 1, 2007;
293(1):
G54 - G65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Singh, B. Voleti, and A. Agrawal
A Novel RBP-J{kappa}-Dependent Switch from C/EBPbeta to C/EBP{zeta} at the C/EBP Binding Site on the C-Reactive Protein Promoter
J. Immunol.,
June 1, 2007;
178(11):
7302 - 7309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bosse, J. J. Fialkovich, C. M. Piaseckyj, E. Beuling, H. Broekman, R. J. Grand, R. K. Montgomery, and S. D. Krasinski
Gata4 and Hnf1{alpha} are partially required for the expression of specific intestinal genes during development
Am J Physiol Gastrointest Liver Physiol,
May 1, 2007;
292(5):
G1302 - G1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kitanaka, U. Sato, and T. Igarashi
Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1{beta} and HNF-1{alpha} and the abnormality of HNF-1{beta} mutants
J. Endocrinol.,
January 1, 2007;
192(1):
141 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ng, K. Nichols, K. O'Rourke, A. Maslen, and G. M. Kirby
Repression of Human GSTA1 by Interleukin-1beta Is Mediated by Variant Hepatic Nuclear Factor-1C
Mol. Pharmacol.,
January 1, 2007;
71(1):
201 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gautier-Stein, C. Zitoun, E. Lalli, G. Mithieux, and F. Rajas
Transcriptional Regulation of the Glucose-6-phosphatase Gene by cAMP/Vasoactive Intestinal Peptide in the Intestine: ROLE OF HNF4{alpha}, CREM, HNF1{alpha}, and C/EBP{alpha}
J. Biol. Chem.,
October 20, 2006;
281(42):
31268 - 31278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bosse, H. M. van Wering, M. Gielen, L. N. Dowling, J. J. Fialkovich, C. M. Piaseckyj, F. J. Gonzalez, T. E. Akiyama, R. K. Montgomery, R. J. Grand, et al.
Hepatocyte nuclear factor-1{alpha} is required for expression but dispensable for histone acetylation of the lactase-phlorizin hydrolase gene in vivo
Am J Physiol Gastrointest Liver Physiol,
May 1, 2006;
290(5):
G1016 - G1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Voleti and A. Agrawal
Regulation of Basal and Induced Expression of C-Reactive Protein through an Overlapping Element for OCT-1 and NF-{kappa}B on the Proximal Promoter
J. Immunol.,
September 1, 2005;
175(5):
3386 - 3390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, M. Capezzone, X. Xu, and J. M. Hershman
Activation of Nicotinamide N-Methyltransferase Gene Promoter by Hepatocyte Nuclear Factor-1{beta} in Human Papillary Thyroid Cancer Cells
Mol. Endocrinol.,
February 1, 2005;
19(2):
527 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, A. Klopot, J.-N. Freund, L. N. Dowling, S. D. Krasinski, and J. C. Fleet
Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1{alpha}
Am J Physiol Gastrointest Liver Physiol,
November 1, 2004;
287(5):
G943 - G953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Divine, L. J. Staloch, H. Haveri, C. M. Jacobsen, D. B. Wilson, M. Heikinheimo, and T. C. Simon
GATA-4, GATA-5, and GATA-6 activate the rat liver fatty acid binding protein gene in concert with HNF-1{alpha}
Am J Physiol Gastrointest Liver Physiol,
November 1, 2004;
287(5):
G1086 - G1099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. van Wering, T. Bosse, A. Musters, E. de Jong, N. de Jong, C. E. Hogen Esch, F. Boudreau, G. P. Swain, L. N. Dowling, R. K. Montgomery, et al.
Complex regulation of the lactase-phlorizin hydrolase promoter by GATA-4
Am J Physiol Gastrointest Liver Physiol,
October 1, 2004;
287(4):
G899 - G909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, C. Coffinier, M. K. Thomas, L. Gresh, G. Eddu, T. Manor, L. L. Levitsky, M. Yaniv, and D. B. Rhoads
Selective Deletion of the Hnf1{beta} (MODY5) Gene in {beta}-Cells Leads to Altered Gene Expression and Defective Insulin Release
Endocrinology,
August 1, 2004;
145(8):
3941 - 3949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Keller, T. Ezaki, R.-J. Guo, and J. P. Lynch
Cdx1 or Cdx2 expression activates E-cadherin-mediated cell-cell adhesion and compaction in human COLO 205 cells
Am J Physiol Gastrointest Liver Physiol,
July 1, 2004;
287(1):
G104 - G114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kitanaka, Y. Miki, Y. Hayashi, and T. Igarashi
Promoter-Specific Repression of Hepatocyte Nuclear Factor (HNF)-1{beta} and HNF-1{alpha} Transcriptional Activity by an HNF-1{beta} Missense Mutant Associated with Type 5 Maturity-Onset Diabetes of the Young with Hepatic and Biliary Manifestations
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1369 - 1378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-I. Leong, C. L Bowlus, J. Tallkvist, and B. Lonnerdal
Iron supplementation during infancy--effects on expression of iron transporters, iron absorption, and iron utilization in rat pups
Am. J. Clinical Nutrition,
December 1, 2003;
78(6):
1203 - 1211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Isshiki, T. Kudo, S. Nishihara, Y. Ikehara, A. Togayachi, A. Furuya, K. Shitara, T. Kubota, M. Watanabe, M. Kitajima, et al.
Lewis Type 1 Antigen Synthase ({beta}3Gal-T5) Is Transcriptionally Regulated by Homeoproteins
J. Biol. Chem.,
September 19, 2003;
278(38):
36611 - 36620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schjerven, P. Brandtzaeg, and F.-E. Johansen
Hepatocyte NF-1 and STAT6 Cooperate with Additional DNA-Binding Factors to Activate Transcription of the Human Polymeric Ig Receptor Gene in Response to IL-4
J. Immunol.,
June 15, 2003;
170(12):
6048 - 6056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Divine, S. P. McCaul, and T. C. Simon
HNF-1{alpha} and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity
Am J Physiol Gastrointest Liver Physiol,
June 9, 2003;
285(1):
G62 - G72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nauze, L. Gonin, B. Chaminade, C. Peres, F. Hullin-Matsuda, B. Perret, H. Chap, and A. Gassama-Diagne
Guinea Pig Phospholipase B, Identification of the Catalytic Serine and the Proregion Involved in Its Processing and Enzymatic Activity
J. Biol. Chem.,
November 8, 2002;
277(46):
44093 - 44099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sauvaget, V. Chauffeton, D. Citadelle, F.-P. Chatelet, C. Cywiner-Golenzer, J. Chambaz, M. Pincon-Raymond, P. Cardot, J. Le Beyec, and A. Ribeiro
Restriction of Apolipoprotein A-IV Gene Expression to the Intestine Villus Depends on a Hormone-responsive Element and Parallels Differential Expression of the Hepatic Nuclear Factor 4alpha and gamma Isoforms
J. Biol. Chem.,
September 6, 2002;
277(37):
34540 - 34548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Boudreau, E. H. H. M. Rings, H. M. van Wering, R. K. Kim, G. P. Swain, S. D. Krasinski, J. Moffett, R. J. Grand, E. R. Suh, and P. G. Traber
Hepatocyte Nuclear Factor-1alpha , GATA-4, and Caudal Related Homeodomain Protein Cdx2 Interact Functionally to Modulate Intestinal Gene Transcription. IMPLICATION FOR THE DEVELOPMENTAL REGULATION OF THE SUCRASE-ISOMALTASE GENE
J. Biol. Chem.,
August 23, 2002;
277(35):
31909 - 31917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Boudreau, E. H. H. M. Rings, G. P. Swain, A. M. Sinclair, E. R. Suh, D. G. Silberg, R. H. Scheuermann, and P. G. Traber
A Novel Colonic Repressor Element Regulates Intestinal Gene Expression by Interacting with Cux/CDP
Mol. Cell. Biol.,
August 1, 2002;
22(15):
5467 - 5478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakaguchi, X. Gu, H. M. Golden, E. Suh, D. B. Rhoads, and H.-C. Reinecker
Cloning of the Human Claudin-2 5'-Flanking Region Revealed a TATA-less Promoter with Conserved Binding Sites in Mouse and Human for Caudal-related Homeodomain Proteins and Hepatocyte Nuclear Factor-1alpha
J. Biol. Chem.,
June 7, 2002;
277(24):
21361 - 21370.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|